Results 221 to 230 of about 8,578 (238)

Immunoconjugates and immunotoxins for therapy of solid tumors

Cancer Chemotherapy and Pharmacology, 1996
I, Hellström, P, Trail, C, Siegall, R, Firestone, K E, Hellström   +4 more
openaire   +2 more sources

Peroxidase-encapsulated cyclodextrin nanosponge immunoconjugates as a signal enhancement tool in optical and electrochemical assays.

In Analysis, 2014
Ewelina Wajs, F. Caldera, F. Trotta, A. Fragoso   +3 more
semanticscholar   +1 more source

Monoclonal antibody immunoconjugates for cancer treatment

Current Opinion in Immunology, 1989
R W, Baldwin, V S, Byers
openaire   +2 more sources

Preparation and functional evaluation of new doxorubicin immunoconjugates containing an acid-sensitive linker on small-cell lung cancer cells

Cancer Immunology, Immunotherapy, 1996
R A Stahel
exaly  

Immunoconjugates for therapy of carcinomas

Immunotechnology, 1996
openaire   +1 more source

Cathepsin B-labile dipeptide linkers for lysosomal release of doxorubicin from internalizing immunoconjugates: model studies of enzymatic drug release and antigen-specific in vitro anticancer activity.

Bioconjugate chemistry, 2002
G. Dubowchik, R. Firestone, L. Padilla, D. Willner, S. Hofstead, Kathy Mosure, J. Knipe, S. Lasch, P. Trail   +8 more
semanticscholar   +1 more source

Development and Activities of the BR96-Doxorubicin Immunoconjugate

2003
I, Hellström, K E, Hellström, P D, Senter   +2 more
openaire   +2 more sources

Use of antibodies and immunoconjugates for the therapy of more accessible cancers

Advanced Drug Delivery Reviews, 2008
David M Goldenberg
exaly  

Contribution of linker stability to the activities of anticancer immunoconjugates.

Bioconjugate chemistry, 2008
S. Alley, Dennis R. Benjamin, S. Jeffrey, N. Okeley, Damon L. Meyer, R. Sanderson, P. Senter   +6 more
semanticscholar   +1 more source

B43-Genistein Immunoconjugate

2020
openaire   +1 more source